STOCK TITAN

CLEVER LEAVES HLDGS INC - CLVR STOCK NEWS

Welcome to our dedicated page for CLEVER LEAVES HLDGS news (Ticker: CLVR), a resource for investors and traders seeking the latest updates and insights on CLEVER LEAVES HLDGS stock.

Clever Leaves Holdings Inc. (symbol: CLVR) is a pioneering company in the medical cannabis industry, headquartered in Colombia. As one of the first Colombian license holders in this field, Clever Leaves has established a robust market presence through its expansive cultivation and extraction operations. By 2023, the company aims to become the world’s largest grower, with over 10 million square feet of cultivation capacity. It also plans to be the largest extractor with pharmaceutical-grade and GMP-certified processing facilities, achieving the lowest cost in cannabis exports globally.

Clever Leaves operates with a differentiated business model that focuses on medical cannabis. They have strategically positioned themselves to lead the global market, bolstering their reputation among regulators, physicians, and key industry stakeholders. The company's significant achievements include launching major cultivation projects and building strong international partnerships.

The company is developing crucial capabilities to excel in the medical cannabis industry, backed by a highly experienced and respected team. Clever Leaves has continuously demonstrated its commitment to quality and compliance, ensuring that all its products meet the highest pharmaceutical standards.

Recent updates include the cessation of production operations in Portugal, which has been classified as discontinued operations as of March 31, 2023. This decision reflects Clever Leaves' focus on optimizing its operational efficiency and financial performance. The company regularly hosts conference calls to keep investors and stakeholders informed about its latest developments and financial status.

For more detailed information or inquiries, investors can reach out to the company's commercial and press contacts:

  • Maria Petsanas / Anne Donohoe, KCSA Strategic Communications, cleverleaves@kcsa.com, +1 917-692-6673
  • Andrew Miller, Head of Global Business Development, Andrew.miller@cleverleaves.com, +1 416-817-1336
  • Julian Wilches, Chief Regulatory Officer, Co-Founder, Julian.wilches@cleverleaves.com, +1-305-927-6642
Rhea-AI Summary

Clever Leaves Holdings (NASDAQ: CLVR, CLVRW) will hold a conference call on November 9, 2022, at 5:00 p.m. ET to discuss its Q3 financial results for the period ending September 30, 2022. The management team will provide insights into financial performance, followed by a Q&A session for participants. Interested parties can join via toll-free or international dial-in numbers, with a replay available post-call until November 16, 2022. For more information, visit Clever Leaves' website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.5%
Tags
none
-
Rhea-AI Summary

Clever Leaves Holdings Inc. has partnered with House of Kush to become the exclusive grower and distributor of House of Kush’s proprietary THC smokable flower genetics outside of the U.S. and Canada. This three-year agreement allows Clever Leaves to cultivate strains such as Bubba Kush Pre-98 and San Fernando Valley OG Kush in Colombia and Portugal. The partnership aims to enhance Clever Leaves' portfolio and expand House of Kush's global reach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
partnership
-
Rhea-AI Summary

Clever Leaves Holdings reported a 27% increase in revenue to $4.7 million for Q2 2022, primarily driven by a 124% rise in cannabinoid revenue to $1.3 million. Adjusted gross profit grew 8% to $2.6 million, despite a gross margin decline to 28%. The company reduced its harvest by 90%, raising all-in costs per gram to $2.26. Notably, net loss decreased to $1.0 million, largely due to a $6.9 million gain from a Cansativa stake sale. Clever Leaves reiterated its 2022 revenue guidance of $20-$25 million and expects to begin dry flower exports in Q4.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) will host a conference call on August 11, 2022 at 5:00 p.m. Eastern time to discuss its second-quarter financial results for the period ending June 30, 2022. The company will issue a financial press release ahead of the call. Interested participants can dial in using the toll-free number 1-855-238-2333 or internationally at 1-412-317-5222 with a Conference ID of 10169279. A replay will be available through August 18, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.02%
Tags
none
-
Rhea-AI Summary

Clever Leaves has successfully entered Israel's flower market by exporting its first commercial high-quality THC flower from its GACP-certified facility in Portugal. This milestone allows medical cannabis patients in Israel to access Clever Leaves' products through a partnership with InterCure. The initial shipment includes a high THC strain, with more genetics to follow as part of a long-term agreement. Clever Leaves aims to expand its footprint in the Israeli market and meet stringent regulatory standards, enhancing its global presence in the medical cannabis sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.94%
Tags
none
-
Rhea-AI Summary

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) announced an expanded partnership with Cantourage GmbH to supply premium cannabinoids from its Portugal facility to German pharmacies. This partnership will allow the distribution of a high-THC dried flower product from the Wappa strain, enhancing the IQANNA brand in the EU market. CEO Andres Fajardo highlighted the commitment to providing high-quality medicinal cannabis solutions. This marks the second product Clever Leaves will offer in Germany, with more to follow soon.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.48%
Tags
partnership
Rhea-AI Summary

Clever Leaves has launched its second medical cannabis product, IQANNA No 10, in collaboration with Cantourage for the German market. This high-THC dried flower, cultivated in Portugal, follows the successful introduction of IQANNA No 7. The partnership aims to expand the availability of high-quality cannabis products in Germany, with plans for more products under the IQANNA brand in the near future. Cantourage processes these flowers, providing an extensive product range to meet growing demand in the EU.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.3%
Tags
partnership
-
Rhea-AI Summary

Clever Leaves Holdings Inc. reports a 50% increase in revenue year-over-year, totaling $5.2 million for Q1 2022. Cannabinoid revenue surged 195% to $2 million. However, the gross margin dropped to 39% from 61.5% due to a $0.8 million inventory write-down. Despite a net loss of $16.1 million, Clever Leaves emphasizes strategic growth in key markets and improvements to its cost structure, projecting full-year revenue between $20 million and $25 million. Significant debt reduction to $2.1 million was also achieved.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
none
-
Rhea-AI Summary

Clever Leaves (NASDAQ: CLVR, CLVRW) is a licensed producer of pharmaceutical-grade cannabinoids, based in Boca Raton, Florida. The Company will participate in several investor conferences in May 2022, including the Canaccord Genuity Annual Cannabis Conference on May 11 at 8:00 a.m. ET and the Cowen European Cannabis Conference on May 12 in Berlin. Additionally, Clever Leaves will attend the H.C. Wainwright Annual Global Investment Conference from May 23 to 26 in Miami. Interested parties can contact the investor relations team for more information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.04%
Tags
conferences
Rhea-AI Summary

Clever Leaves Holdings (NASDAQ: CLVR, CLVRW) will host a conference call on May 12, 2022, at 5:00 p.m. ET to discuss Q1 results ending March 31, 2022. A press release detailing financial results will precede the call. The call will include a Q&A segment and will be accessible via toll-free and international dial-in numbers. A replay will be available post-call until May 19, 2022. Clever Leaves operates as a licensed producer of pharmaceutical-grade cannabinoids, focusing on sustainable production methods in Colombia and Portugal.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.05%
Tags
none

FAQ

What is the current stock price of CLEVER LEAVES HLDGS (CLVR)?

The current stock price of CLEVER LEAVES HLDGS (CLVR) is $0.000001 as of October 15, 2024.

What is the market cap of CLEVER LEAVES HLDGS (CLVR)?

The market cap of CLEVER LEAVES HLDGS (CLVR) is approximately 5.3M.

What is Clever Leaves Holdings Inc.?

Clever Leaves Holdings Inc. (CLVR) is a leading company in the medical cannabis industry, headquartered in Colombia. It focuses on cultivation and extraction of cannabis with pharmaceutical-grade and GMP-certified facilities.

Where is Clever Leaves located?

Clever Leaves is headquartered in Colombia, with operations extending globally.

What are Clever Leaves' main products?

Clever Leaves produces medical-grade cannabis products, focusing on high-quality cultivation and extraction processes.

What is the cultivation capacity of Clever Leaves?

By 2023, Clever Leaves aims to have over 10 million square feet of cultivation capacity, making it the world’s largest grower.

What recent changes has Clever Leaves undergone?

Clever Leaves has discontinued its production operations in Portugal as of March 31, 2023, to optimize efficiency and financial performance.

How does Clever Leaves ensure product quality?

Clever Leaves adheres to pharmaceutical-grade standards and GMP-certified processes to ensure high-quality products.

Who are the key contacts at Clever Leaves?

Key contacts include Maria Petsanas and Anne Donohoe from KCSA Strategic Communications, Andrew Miller, Head of Global Business Development, and Julian Wilches, Chief Regulatory Officer and Co-Founder.

How can investors get updates about Clever Leaves?

Investors can participate in the regular conference calls hosted by Clever Leaves or contact their press and commercial representatives for more information.

What industry is Clever Leaves involved in?

Clever Leaves operates in the medical cannabis industry, focusing on cultivation and extraction.

What sets Clever Leaves apart in the cannabis industry?

Clever Leaves stands out due to its large-scale cultivation capacity, pharmaceutical-grade processing, global partnerships, and commitment to quality and compliance.

CLEVER LEAVES HLDGS INC

Nasdaq:CLVR

CLVR Rankings

CLVR Stock Data

5.26M
1.76M
30.75%
2.31%
2.02%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TOCANCIPA - CUNDINAMARCA